94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Jun Zhang1Zunyuan Yang2Xue Jia3
Xinxin Li1Xiangyang Wang1Hua Rong1Yinan Liang2Wen Zeng2Wei Jia4,5*
Xiaohui Ma1*- 1The State Key Laboratory of Core Technology in Innovative Chinese Medicine, Tasly Academy, Tasly Holding Group Co., Ltd, Tianjin, China
- 2PriMed Non-Human Primate Research Center of Sichuan PriMed Shines Bio-Tech Co., Ltd., Ya’an, Sichuan, China
- 3China Pharmaceutical University, Nanjing, China
- 4Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
- 5School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China
by Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022). Front. Pharmacol. 13:1017433. doi: 10.3389/fphar.2022.1017433
In the original article, there was an error in the name of Traditional Chinese Medicine throughout the article. The name was displayed as “QiShenYiQi Dripping Pills (T101)” or “QSYQ (T101)”. The corrected name is “QiShenYiQi Dripping Pills” or “QSYQ”. The code number T101 has been deleted in the title and Figure 1.
FIGURE 1
FIGURE 1. The flowchart of the study.
The corrected title appears below.
“Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities”.
The corrected Figure 1 and its caption “The flowchart of the study.” appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: heart failure, QSYQ, SHR, network pharmacology, metabolomics
Citation: Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022) Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities. Front. Pharmacol. 13:1080645. doi: 10.3389/fphar.2022.1080645
Received: 26 October 2022; Accepted: 04 November 2022;
Published: 21 November 2022.
Edited and reviewed by:
Wei Deng, Renmin Hospital of Wuhan University, ChinaCopyright © 2022 Zhang, Yang, Jia, Li, Wang, Rong, Liang, Zeng, Jia and Ma. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Jia, d2VpamlhMUBoa2J1LmVkdS5oaw==; Xiaohui Ma, bWF4aWFvaHVpQHRhc2x5LmNvbQ==